| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |